Follow
Mark van Berge Henegouwen
Mark van Berge Henegouwen
Professor of Surgery
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
Preoperative chemoradiotherapy for esophageal or junctional cancer
P van Hagen, M Hulshof, JJB Van Lanschot, EW Steyerberg, ...
New England Journal of Medicine 366 (22), 2074-2084, 2012
53532012
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ...
The lancet oncology 16 (9), 1090-1098, 2015
23072015
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
SSAY Biere, MI van Berge Henegouwen, KW Maas, L Bonavina, ...
The Lancet 379 (9829), 1887-1892, 2012
18132012
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ...
The Lancet 396 (10243), 27-38, 2020
17932020
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
528*2021
Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial
J Straatman, N Van Der Wielen, MA Cuesta, F Daams, JR Garcia, ...
Annals of surgery 266 (2), 232-236, 2017
5122017
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials
V Oppedijk, A van der Gaast, JJB van Lanschot, P van Hagen, R van Os, ...
Journal of Clinical Oncology 32 (5), 385-391, 2014
4912014
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, ...
The lancet oncology 19 (5), 616-628, 2018
4702018
Medical liability insurance claims on entry-related complications in laparoscopy
J Wind, JEL Cremers, MI van Berge Henegouwen, DJ Gouma, FW Jansen, ...
Surgical endoscopy 21, 2094-2099, 2007
4262007
Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant
MI van Berge Henegouwen, LT De Wit, TM Van Gulik, H Obertop, ...
Journal of the American College of Surgeons 185 (1), 18-24, 1997
3801997
Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial
BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, ...
Journal of Clinical Oncology 39 (18), 1995-2004, 2021
3612021
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
M Arnold, J Ferlay, MI van Berge Henegouwen, I Soerjomataram
Gut 69 (9), 1564-1571, 2020
3572020
Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients
MI van Berge Henegouwen, TM van Gulik, LT DeWit, JH Allema, ...
Journal of the American College of Surgeons 185 (4), 373-379, 1997
2941997
Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study
KN Phoa, RE Pouw, FGI Van Vilsteren, CMT Sondermeijer, FJW Ten Kate, ...
Gastroenterology 145 (1), 96-104, 2013
2852013
Learning curve and associated morbidity of minimally invasive esophagectomy: a retrospective multicenter study
F van Workum, MHBC Stenstra, GHK Berkelmans, AE Slaman, ...
Annals of surgery 269 (1), 88-94, 2019
2652019
Perioperative strategy in colonic surgery; LA paroscopy and/or FA st track multimodal management versus standard care (LAFA trial)
J Wind, J Hofland, B Preckel, MW Hollmann, PMM Bossuyt, DJ Gouma, ...
BMC surgery 6, 1-8, 2006
2522006
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ...
The Lancet Oncology 19 (7), 965-974, 2018
2362018
Defining benchmarks for transthoracic esophagectomy: a multicenter analysis of total minimally invasive esophagectomy in low risk patients
HM Schmidt, SS Gisbertz, J Moons, I Rouvelas, J Kauppi, A Brown, E Asti, ...
Annals of surgery 266 (5), 814-821, 2017
2342017
Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial
KW Maas, MA Cuesta, MI van Berge Henegouwen, J Roig, L Bonavina, ...
World journal of surgery 39 (8), 1986-1993, 2015
2152015
A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands
MFJ Seesing, SS Gisbertz, L Goense, R Van Hillegersberg, HM Kroon, ...
Annals of surgery 266 (5), 839-846, 2017
2112017
The system can't perform the operation now. Try again later.
Articles 1–20